ID   KE37/1
AC   CVCL_B7RK
SY   KE37-1
DR   cancercelllines; CVCL_B7RK
DR   Wikidata; Q112929942
RX   PubMed=6151082;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 7881; NOTCH1; Simple; p.Gln2459Ter (c.7375C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 9585; PTCH1; Simple; p.Arg571Gln (c.1712G>A); ClinVar=VCV000819886; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 9884; RB1; Simple; p.Gly310Glu (c.929G>A); ClinVar=VCV000237678; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Heterozygous (from parent cell line).
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1327 ! KE-37
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 05-10-23; Version: 4
//
RX   PubMed=6151082; DOI=10.1016/S0140-6736(84)91666-0;
RA   Popovic M., Read-Connole E.L., Gallo R.C.;
RT   "T4 positive human neoplastic cell lines susceptible to and permissive
RT   for HTLV-III.";
RL   Lancet 324:1472-1473(1984).
//